FOXO4-DRI Side Effects
FOXO4-DRI is a senolytic peptide that selectively induces apoptosis in senescent cells. It has been studied primarily in animal models and human data is very limited. Physician supervision is particularly important for this compound.
This page is for educational purposes only and is not medical advice. Side effects vary between individuals. All protocols at Peptides Thailand are individually prescribed by licensed physicians. Contact your doctor with any concerns during treatment.
FOXO4-DRI's published human data is very limited. The mechanism is studied primarily in animal models. Informed physician supervision is essential.
Side effects to be aware of
Injection site reactions
CommonMild redness or swelling at the injection site.
Transient fatigue
UncommonSome patients report fatigue during the days following administration, potentially related to the senolytic mechanism and immune response to cleared cells.
Mild inflammatory response
UncommonClearance of senescent cells may trigger a local or mild systemic inflammatory response. This is expected as part of the mechanism.
Monitoring
Inflammatory markers and general wellbeing should be assessed after each administration cycle.
Who is a good candidate?
- Adults pursuing longevity protocols under physician supervision and with informed consent about limited human data
- Those expecting immediate measurable results (senolytic effects are cumulative and not immediately apparent)
- Patients with active cancer without oncology clearance
Contraindications
Your physician screens for these conditions before prescribing. Do not attempt to self-prescribe.
- Active cancer (senescent cells may play protective roles in some contexts - discuss with oncologist)
- Recent surgery (senescent cells play roles in wound healing)
- Pregnancy and breastfeeding
When to contact your physician
- Nausea, vomiting, or digestive symptoms that are severe or do not ease within two weeks
- Any chest pain, palpitations, or significant change in heart rate
- Signs of allergic reaction: rash, hives, swelling of the face or throat, or difficulty breathing
- Injection site reactions that worsen, spread, or do not resolve within 72 hours
- Any new or worsening symptoms that concern you, regardless of whether they seem related to your protocol
- Changes in any monitored values outside the range your physician specified
If you are ever unsure, contact your physician. That is what they are there for.
Learn more
Have questions about FOXO4-DRI?
Message our team on WhatsApp. We typically reply within minutes.
Message us on WhatsApp